Urogen Pharma's market cap is currently ―. The company's EPS TTM is $-3.143; its P/E ratio is ―; Urogen Pharma is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.74. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Income Statement	-
Total Revenue	$ 25.20M	$ 21.85M	$ 18.78M	$ 23.53M	$ 20.85M
Gross Profit	$ 22.75M	$ 19.62M	$ 17.05M	$ 21.24M	$ 18.48M
EBIT	$ -17.55M	$ -29.90M	$ -29.79M	$ -14.61M	$ -18.07M
EBITDA	$ -18.55M	$ -29.23M	$ -29.43M	$ -14.56M	$ -17.44M
Net Income Common Stockholders	$ -23.67M	$ -33.40M	$ -32.29M	$ -26.02M	$ -21.88M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 249.57M	$ 241.08M	$ 164.04M	$ 136.97M	$ 147.42M
Total Assets	$ 301.94M	$ 281.85M	$ 200.57M	$ 178.31M	$ 193.63M
Total Debt	$ ―	$ ―	$ ―	$ ―	$ ―
Net Debt	$ ―	$ ―	$ ―	$ ―	$ ―
Total Liabilities	$ 276.43M	$ 251.53M	$ 240.71M	$ 243.52M	$ 235.63M
Stockholders Equity	$ 25.52M	$ 30.31M	$ -40.13M	$ -65.21M	$ -41.99M
Cash Flow	-
Free Cash Flow	$ -27.76M	$ -23.83M	$ -31.73M	$ -13.05M	$ -17.40M
Operating Cash Flow	$ -27.66M	$ -23.75M	$ -31.73M	$ -13.00M	$ -17.30M
Investing Cash Flow	$ -106.75M	$ 12.00M	$ 13.52M	$ -11.34M	$ 401.00K
Financing Cash Flow	$ 39.61M	$ 100.28M	$ 54.66M	$ 40.00K	$ 116.08M

Currency in USD

Urogen Pharma Earnings and Revenue History

Income Statement >

Urogen Pharma Debt to Assets

Balance Sheet >

Urogen Pharma Cash Flow

Cash Flow >

Urogen Pharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing